Could Proximity of Toilets to Sinks in Medical Intensive Care Units Contribute to Hospital-Acquired Infections?

Microbiologists will be interested to learn of new research designed to better identify sources of hospital-acquired infections, including investigating possibilities that have not been previously considered Does the proximity of toilets to sinks in medical intensive care units (MICUs) affect the health and recovery of the patients staying there? Until recently, that wasn’t questioned. But clinical laboratory managers will be interested to learn why researchers now believe this could very well...

Researchers at University of British Columbia Use Human Gut Bacteria to Convert A/B Blood into Universal Type-O

If this technology proves viable on large scale, medical laboratories in hospitals that manage blood banks could have larger supplies of universal blood units Once again, the amazing human microbiome is at the heart of a new scientific breakthrough that could offer new tools for clinical laboratories and provide much needed resources to emergency departments and hospitals. Canadian researchers at the University of British Columbia (UBC) in Vancouver have discovered a microbe in the human gut...

Does New Opioid Law Require Clinical Laboratories to Change How They Pay Sales Employees?

Recently enacted EKRA law prohibits payment activities that were legal under the previous Anti-Kickback Statute, confusing clinical laboratories and legal experts alike There is a relatively new law on the books that impacts clinical laboratories, and lab leaders tasked with ensuring compliance with federal statutes need to fully understand it because getting it wrong could have dire consequences. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for...

Reappearance of Victorian Era Diseases Highlight Importance of Clinical Laboratory Vigilance

As admissions for scarlet fever, whooping cough, scurvy, and other “Dickensian Era” diseases rise, medical laboratories must continue to consider uncommon causes when performing tests and providing data to physicians developing treatment plans Resurgence in once-rare diseases and conditions in both the United Kingdom and the United States highlight the importance of recognizing the unlikely and unexpected when ordering and performing medical laboratory testing. While a large portion of tests...

PAMA Price Reporting Update: Insights to Help Prepare to Meet the Requirement

Prior (2018) price reporting cycle offers lessons that can help clinical laboratory benefit administrators and personnel take an informed approach to meeting the requirements of the Protecting Access to Medicare Act of 2014 (PAMA) With the PAMA Private Payor Price Reporting period under way, some clinical laboratories may be grappling with questions about the new requirements. Under PAMA, applicable labs must report private payer data on selected Clinical Diagnostic Laboratory Tests (CDLTs) to...

Medicare-for-All Bill Has Little Chance of Passage in Congress, Even as Universal Healthcare Debate Gains Momentum Among Democratic Presidential Hopefuls

Massive government takeover of healthcare would create single-payer healthcare system, doing away with Medicare Advantage and individual choice All clinical laboratories and anatomic pathology groups have a strong interest in how any reform of US healthcare at the federal level might be accomplished. In that spirit, Dark Daily is providing a quick overview of the Medicare for All Act of 2019 (HR 1384). The name is misleading. The bill would actually end Medicare and all private health...